Francois
These include abnormalities in the growth and development of these vessels, arteries, capillaries, veins and lymphatic vessels. Many are found in human disorders including cardiovascular illness, solid cancer metastasis and inflammatory diseases.
We will be looking to determine the molecular events that direct and influence the construction of the ‘vascular tree’ (the network of blood and lymph vessels throughout the body). To find where these diseases and disorders have a genetic cause. We aim to identify opportunities for novel therapies to be assessed and generated.
The main focus of the research program will revolve around the biology of a class of protein known as transcription factors (TFs). These proteins act as molecular switches or as the control panel of the genome to turn on and off genetic pathways which drive vascular development.
Until recently TFs were labelled as “undruggable” but recent technology advances have opened up new research directions to efficiently manipulate these targets pharmacologically. The long term goal is to design new treatments that fine-tune gene expression to improve the management of vascular disorders.
Undertaking a highly strategic methodology to this activity, the new laboratory’s research program will be multi-disciplinary in nature, encompassing developmental biology, disease model systems, complemented by biophysics and genomics approaches.
The main focus of the research program will revolve around the biology of a class of protein known as transcription factors (TFs). These proteins act as molecular switches or as the control panel of the genome to turn on and off genetic pathways which drive vascular development.
Until recently TFs were labelled as “undruggable” but recent technology advances have opened up new research directions to efficiently manipulate these targets pharmacologically. The long term goal is to design new treatments that fine-tune gene expression to improve the management of vascular disorders.
Undertaking a highly strategic methodology to this activity, the new laboratory’s research program will be multi-disciplinary in nature, encompassing developmental biology, disease model systems, complemented by biophysics and genomics approaches.